Cambridge, MA, United States of America

Janid A Ali

This inventor holds 1 USPTO granted patent. Top assignee: Infinity Pharmaceuticals, Inc.. Active years: 2015.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Janid A. Ali in Biomedicine

Introduction

Janid A. Ali is a prominent inventor based in Cambridge, Massachusetts. With a focus on biomedicine, he has made significant contributions to the field through his innovative research and developments. His work has led him to secure a patent that showcases his expertise in the biotechnology sector.

Latest Patents

Janid A. Ali holds a patent for "Anti-fatty acid amide hydrolase-2 antibodies and uses thereof." This invention pertains to antibodies that specifically bind to fatty acid amide hydrolases. The methods of utilizing these antibodies are integral to advancing therapeutic applications in the medical field.

Career Highlights

Currently, Janid A. Ali is employed at Infinity Pharmaceuticals, Inc., a leading company focusing on the discovery and development of innovative cancer drugs. His role there allows him to bring his valuable insights and inventive ideas into practical applications that can benefit patients and the healthcare industry.

Collaborations

Throughout his career, Janid has collaborated with notable coworkers, including James Brownell and Erin Brophy. These partnerships highlight the emphasis on teamwork and shared knowledge in advancing research and innovation within the pharmaceutical and biotechnology sectors.

Conclusion

Janid A. Ali exemplifies the impact that a dedicated inventor can have in biomedicine. His patent and ongoing work at Infinity Pharmaceuticals, Inc. contribute to significant advancements that hold promise for future medical treatments. The collaboration with esteemed colleagues further enhances the potential for transformative innovations in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…